INTRODUCTION
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MATERIALS AND METHODS Study area:
The study was based in the household survey of VL discharged patients from districts, zonal and referral hospitals of typical disease-endemic regions of VL in Eastern Nepal. These districts are Sunsari, Saptari and Siraha situated in the plain foot hills of Himalayas and have the favorable environment for transmission of VL such as alluvial soil, high sub-soil water, a monthly mean maximum temperature below 37°C, a monthly mean minimum temperature above 7.2°C
, an annual rainfall 1,250 mm, a mean annual relative humidity 70%, abundant vegetation and an altitude < 600 meters. The climate of the study areas is similar with no wide variation. These conditions are highly suitable for an abundance of sand flies facilitating perennial transmission of VL. Agriculture and its associated activities is the mainstay of the economy of these areas. Study design: This was a cr oss-sectional study. The sample units were clinically and parasitological confirmed VL from districts, zonal and referral hospitals of Eastern Nepal. Sample size and sampling: A total 500 cases diagnosed as VL from the eastern Nepal in the year April 2012 to August 2013 were the sample included in the study. District wise patient list was made and total 172 discharged patients were selected randomly. Patients were identified by rechecking their identification which was written during the time of admission at hospitals and interviewed at their homes in the field. Informed consent was obtained from all cases before including them into this study. The study was reviewed and approved by the Research Committee and Ethical Board of BPKIHS. Tools and techniques of data collection: Pr e tested structured questionnaire was used to collect information regarding the socio demographic variables, illness of disease onset cost, cost during treatment, discharged and follow up as well as duration of treatment in various levels of facilities, of VL patients. Data analysis: Collected data were decoded and scrutinized by investigator for accuracy and consistency. Data were entered in Microsoft Excel 2007 and converted it into Statistical Package for Social Sciences 11.5 version (SPSS, Inc. Chicago, IL). Data were validated by logical and range checks by SPSS. Descriptive statistics were calculated to find out the expenditure of VL treatment. The correlation of treatment costs with hospital stay was interpreted by Pearson correlation. All the tests were considered significant if p value < 0.05.
RESULTS
The socio demographic variables like age group, educational status, religion, mother tongue, caste, family types and sex of decision maker in family were recorded ( Table 1 ). The result revealed that all cases from three districts were similar in socio demographic characteristics. The findings revealed that most of the VL patients belonged to low socioeconomical strata of the community. About half of the patients were in the age group 41 to 60 years and almost 70% of the patients were illiterate. Maximum patients were Hindu by religion. About two third of patients were Maithali speaking and about one third were Tharu speaking. More than one third of patients were from Terai Janajati (majority Tharus). The sleeping habit of VL cases before coming for treatment was also recorded (Table 2 ). Almost all of the patients (94.19%) were sleeping on ground floor and almost half had the habit of sleeping on muddy ground floor. More than one fourth never used bed nets, other quarter used only during summer and approximately half of them always used bed or cot regularly while sleeping. Only one third patients used double-bed net before coming for treatment. More than 90% patients had used very big-hole net before treatment. For the cost estimation, we tried to cover all type of costs which was reported by the VL cases and his/ her family members and number of days lost due to disease was calculated ( Table 3) . The average annual income of KA patients' family was found to be Rs 12,321 (US $ 116.23) and there was not much variation between the districts. The average cost incurred on VL treatment during hospital stay was Rs. 4032.67±1034.14, which is nearly one third of the annual income of the patients' family. The item wise cost on VL patients was found as follows: cost before diagnosis was Rs 2379.94±265.31, Doctor/Institutional registration fee Rs. 60±20, cost of drugs during hospitalization was Rs 200.15 ± 24.12, Laboratory Investigation cost during hospitalization was Rs 290.00±45.34,
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Hospital admission service cost Rs 65 ±10 and cost of drugs after discharge was found to be Rs 475.00 ± 115.00. It was also found that on an average of Rs. 3652.90±1534.11 was spent on the cost related to food, travel and attendants' expenditure. Cost for follow-up was Rs 360.34±49.14. On average, patients got VL treatment at district hospital after 45 ± 16 days of the disease. They got treatment at district level on an average of 17 ± 8 days after being referred from the community level. The average length of stay was 16 ± 7 days at hospital. Out of 172 VL cases only 83.7% of patients came for follow-up after 30 ± 5 days from the date of discharge. Out of the total cost Rs 7247.95 ± 3672.90 after diagnosis, 75.04% cost was spent on travel, accommodation, food, and patients' attendant expenditure. It was also found that the total cost were significantly varying in the three 
DISCUSSION
According to the national policy, the treatment cost of VL cases is 100% free. Delay in case detection and treatment of VL is one of the main problems in Nepal. [1] [2] [3] [4] [7] [8] [9] The reason for this delay could be because of very poor people living in the VL endemic area. 8, 9 Initially all cases of VL spend their money in medical pharmacy/shops for sub standard investigation. 1 So the village level health systems hardly detect and refer the cases of VL to the
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Baral D As per national guideline, a kala azar case needs to be treated in less than two weeks, 3 but our findings showed that the time taken between onset of the disease and treatment is more than two months. So the delay in treatment not only increases the cost of treatment but also takes longer time in hospital stay1 which was also evident in our study. The average length of hospital stay in kala azar treatment was 17 days, which was longer as compared to other diseases. 1, 3, 9, 10 There was statistically significant positive correlation between hospitalization days and total treatment cost (r= 0.715 and p=0.031). The longer duration of hospital stay would incur higher the treatment cost, thus we can argue that reducing the length of hospitalization days can reduce treatment cost (direct and indirect cost). Although national policy regarding treatment of Kala-azar is free in Nepal, 2,3,7 but majority of the cost is incurred by indirect costs and investigations which is evident in this study where more than 75.04% expenditure was for traveling, food and investigation. Various studies done on Kala-azar reveal that the extra expenses in VL treatment and loss of income due to no-work days of patients and their attendants has negative impact on the low earning families. 1, 5, 7, 8 Studies have shown Kala-azar is a serious public health problem due to reason of not having enough community level hospital for diagnosis in the endemic region. [11] [12] [13] Poor socio demographic factors in the endemic areas has remained as the major factor for the delay in treatment after referral from community. 11, 14, 15 The nature of disease can make uncertainty to diagnose by untrained health staffs of community which exacerbates condition of sickness and becomes fatal if untreated. 1, 7, 9 Very less number of community health workers involved in VL control program was found as the major constraints for timely referral of VL cases.
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CONCLUSION
The expenditure on treatment of disease kala azar still remains high for developing countries like Nepal though government has free treatment policy for this illness. We have little information to determine the expenses on different items over an extended period of time. So with limited information, this study provides the treatment expenditure on infectious disease and its relation with hospital stay among the poor households in Eastern Nepal. This study suggests that the investment in outreach facilities for early detection of VL patients in community may reduce hospital stay thereby reducing treatment cost of the disease.
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